ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oncocyte Corporation

Oncocyte Corporation (OCX)

2.21
-0.02
(-0.90%)
At close: January 10 4:00PM
2.21
0.00
( 0.00% )
After Hours: 5:16PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.21
Bid
2.10
Ask
2.52
Volume
8,183
2.13 Day's Range 2.32
1.97 52 Week Range 3.5687
Market Cap
Previous Close
2.23
Open
2.20
Last Trade
60
@
2.21
Last Trade Time
16:00:00
Financial Volume
$ 18,282
VWAP
2.2341
Average Volume (3m)
89,510
Shares Outstanding
16,835,247
Dividend Yield
-
PE Ratio
-1.30
Earnings Per Share (EPS)
-1.71
Revenue
7.27M
Net Profit
-28.72M

About Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Irvine, California, USA
Founded
-
Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was $2.23. Over the last year, Oncocyte shares have traded in a share price range of $ 1.97 to $ 3.5687.

Oncocyte currently has 16,835,247 shares outstanding. The market capitalization of Oncocyte is $37.54 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.30.

OCX Latest News

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory and reimbursement supportWill assist business...

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief...

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its...

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phaseFDA...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-6.751054852322.372.44992.18231702.28427784CS
4-0.27-10.88709677422.482.691.97727182.26787838CS
12-0.91-29.16666666673.123.21.97895102.52336473CS
26-0.76-25.58922558922.973.47991.97537992.68878695CS
52-1.1-33.23262839883.313.56871.97483672.73082397CS
156-38.79-94.60975609764145.21.9723331914.80632715CS
260-67.59-96.833810888369.81251.9730749843.36029311CS

OCX - Frequently Asked Questions (FAQ)

What is the current Oncocyte share price?
The current share price of Oncocyte is $ 2.21
How many Oncocyte shares are in issue?
Oncocyte has 16,835,247 shares in issue
What is the market cap of Oncocyte?
The market capitalisation of Oncocyte is USD 37.54M
What is the 1 year trading range for Oncocyte share price?
Oncocyte has traded in the range of $ 1.97 to $ 3.5687 during the past year
What is the PE ratio of Oncocyte?
The price to earnings ratio of Oncocyte is -1.3
What is the cash to sales ratio of Oncocyte?
The cash to sales ratio of Oncocyte is 5.12
What is the reporting currency for Oncocyte?
Oncocyte reports financial results in USD
What is the latest annual turnover for Oncocyte?
The latest annual turnover of Oncocyte is USD 7.27M
What is the latest annual profit for Oncocyte?
The latest annual profit of Oncocyte is USD -28.72M
What is the registered address of Oncocyte?
The registered address for Oncocyte is 15 CUSHING, IRVINE, CALIFORNIA, 92618
What is the Oncocyte website address?
The website address for Oncocyte is www.oncocyte.com
Which industry sector does Oncocyte operate in?
Oncocyte operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TRAWTraws Pharma Inc
$ 11.23
(39.33%)
138.23k
SAGESage Therapeutics Inc
$ 7.44
(34.05%)
545.56k
EHGOEshallgo Inc
$ 4.00
(22.32%)
862
RAYRaytech Holding Ltd
$ 1.61
(19.26%)
450.26k
TIRXTian Ruixiang Holdings Ltd
$ 1.96
(17.37%)
2.93M
TOIIWOncology Institute Inc
$ 0.01
(-35.90%)
3k
VMARVision Marine Technologies Inc
$ 1.80
(-16.28%)
1.49M
CTCXCarmell Corporation
$ 0.4314
(-12.38%)
69.41k
RELIReliance Global Group Inc
$ 1.709
(-11.45%)
18.51k
DRCTDirect Digital Holdings Inc
$ 1.47
(-10.37%)
186.29k
GCTKGlucoTrack Inc
$ 0.133
(13.68%)
16.08M
CDTConduit Pharmaceuticals Inc
$ 0.126
(2.19%)
8.98M
RGTIRigetti Computing Inc
$ 8.12
(-9.07%)
8.79M
SVMHSRIVARU Holding Ltd
$ 0.0627
(1.46%)
3.57M
NVDANVIDIA Corporation
$ 135.81
(-0.07%)
3.38M

Discussion

View Full Feed
FNM500K FNM500K 1 minute ago
https://www.barrons.com/articles/bill-ackman-fannie-mae-stock-freddie-6e7141d6?siteid=yhoof2
FNMA
MartinLutherKing MartinLutherKing 2 minutes ago
Are you sure it’s a scam brother
RNAZ
georgejjl georgejjl 2 minutes ago
Anavex 3-71

Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline ... displaying Alzheimer-like amyloid pathology

"...The application of the selective allosteric M1 muscarinic and sigma-1 receptor agonist, AF710B (aka ANAVEX3-71), has shown
AVXL
StockInfo11 StockInfo11 2 minutes ago
Vior Inc. (VIO.v VIORF) reports high-grade gold results from its ongoing +60,000m drill program at the Belleterre Gold Project, Quebec. Highlights include 15.9 g/t Au over 1.2m at Vein #12 and 10.4 g/t Au over 1.2m at the Aubelle target. Drilling confirmed 500m depth extensions, with plans to add a
VIO
BOREALIS BOREALIS 3 minutes ago
See photos of smoke, smoldering homes and flames as wildfires ravage Los Angeles area

By PETER PRENGAMAN, JAE C. HONG, JOHN LOCHER and ALYSSA GOODMAN
Updated 5:01 PM CST, January 10, 2025

Four days after powerful winds gave fuel to what began as small fires in
Fred Flies Fred Flies 3 minutes ago
This scam is still a thing?!
OZSC
Explosivo Explosivo 3 minutes ago
That’s a lot of words to say, “I’m old”
HMBL
nagoya1 nagoya1 4 minutes ago
Ouch? Duh! Ahhh? Ooops?
No pompoms but drippity drip.
Ask skaterboy how his job search is coming along with Nemia’s reference letter.
Fnma
FNMA
StockInfo11 StockInfo11 4 minutes ago
New Era Helium Corp. (NASDAQ: NEHC) is a production-stage helium supplier with 1.5 BCF of proven reserves on 137,000 acres in the Permian Basin. Operating 400 wells, NEHC has $113M in long-term offtake deals and is expanding with a helium plant and net-zero data center venture. Deck➡️ https://www.ne
NEHC
baerga baerga 5 minutes ago
CNSP @ .12 for next week last penny to not have a big run
CNSP
Meowza Meowza 6 minutes ago
Defensive much about your yogurt consumption?
AMRN
moondogaz moondogaz 6 minutes ago
Clouds don't fly..lol. but rumor has it musk is working on flying bears...lo-freekn-l....
HMBL
biotech_researcher biotech_researcher 6 minutes ago
How many more days can this stay below 1 dollar before it is delisted?
AMRN
gfp927z gfp927z 6 minutes ago
Derf, Healthcare costs in the US will always be in crisis as long as the average American is 50 lbs overweight, eats crappy processed 'food' laced with chemicals, and has 'leaky gut' due to the lack of a healthy gut microbiome. The US spends the most on healthcare, and has the least healthy popul
tw0122 tw0122 7 minutes ago
Live from style="font-size: 1em; caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif"SAN DIEGO style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif; font-size: medium; background-color: rgba
TRAW
Zorax Zorax 7 minutes ago
The only problem we have on the food front is cost, and that began with COVID.

Yes. And the other problem is corporations and smaller companies have gotten fat on the artificial high prices since.

Like walmart, wanting to and probably are raising prices across their sto
navycmdr navycmdr 7 minutes ago
Jan 16th nomination hearing for

Treasury Secretary Bessent ...

https://investorshub.advfn.com/uimage/uploads/2025/1/10/tueclScreenshot_20250110_153640_Chrome.jpg
FNMA
The Great Pumpkin The Great Pumpkin 8 minutes ago
I’d suggest you do some DD on what the private market thinks NLM is worth.

FAFO

#scam
LWLG
dinogreeves dinogreeves 9 minutes ago
Very much true. Permits will push it higher, but the most this will do after the permits is 38-48 cents, but according to you permits will take 240-270 days. They haven't even filed the amended application. FID is going to change everything and I stand by it. Forget what happened in the past.
TGLO
art2426 art2426 10 minutes ago
>>>If we get all three, Katie bar the door. The share price could explode in a heartbeat.
BIEL
The Great Pumpkin The Great Pumpkin 11 minutes ago
Good job. Stock is going back to .60.

FAFO

#scam
LWLG
Explosivo Explosivo 11 minutes ago
So you’re not some old dude? Huggy bear? Your name is a reference to a thing that most people here who are positive weren’t even alive for. Really? You’re fooling no one. At least admit it. You’re old. It’s ok.
HMBL
fuagf fuagf 12 minutes ago
Thomas, Alito, Gorsuch, Kavanaugh see kingship in Trump. Merchan, true patriot. Roberts and Barrett, firm.

"Judge upholds Trump’s felony conviction, but does not plan to order jail time
"Trump indictment follows 50 years of investigation on many fronts""

Relat

Your Recent History

Delayed Upgrade Clock